Globus Medical

$61.60
(as of May 20, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Globus Medical

Stock Price
$61.60
Ticker Symbol
GMED
Exchange
NYSE

Industry Information for Globus Medical

Sector
Healthcare
Industry
Medical Devices

Company Description for Globus Medical

Country
USA
Full Time Employees
5,300

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Fundamentals for Globus Medical

Market Capitalization
$8,291,964,416
EBITDA
$720,675,008
Dividends per Share
P/E Ratio
45.71
Forward P/E Ratio
19.46
Earnings per Share
$1.34
Earnings per Share Estimate Next Year
Profit Margin
7.39%
Shares Outstanding
112,949,000
Percent Owned by Insiders
0.69%
Percent Owned by Institutions
100.92%
52-Week High
52-Week Low

Technical Indicators for Globus Medical

50-Day Moving Average
200-Day Moving Average
RSI
39.37
2.77

Analyst Ratings for Globus Medical

Strong Buy
5
Buy
5
Hold
5
Sell
0
Strong Sell
0

News About Globus Medical

May 19, 2025, 7:40 AM EST
The United States market has experienced a positive trend, rising 2.9% over the last week and 12% over the past year, with earnings projected to grow by 14% annually in the coming years. See more.
May 18, 2025, 10:00 AM EST
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Globus Medical, Inc.  See more.
May 16, 2025, 8:23 AM EST
Investors were underwhelmed by the solid earnings posted by Globus Medical, Inc. See more.
May 15, 2025, 11:31 PM EST
Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Enovis (NYSE:ENOV) and its peers. See more.